(Q43863856)

27 November 2017

Pumactant and poractant alfa in respiratory distress syndrome (English)

1 reference

27 November 2017

A D Wardhaugh

1

1 reference

PubMed ID

11085711

27 November 2017

J W Matthes

series ordinal

2

1 reference

PubMed ID

11085711

27 November 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

27 November 2017

1 reference

27 November 2017

356

1 reference

27 November 2017

9231

1 reference

27 November 2017

765-766

1 reference

Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902643-X

7 January 2021

Which surfactant for treatment of respiratory-distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902643-X

7 January 2021

Dry artificial lung surfactant and its effect on very premature babies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902643-X

7 January 2021

Two controlled trials of dry artificial surfactant: early effects and later outcome in babies with surfactant deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902643-X

7 January 2021

Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902643-X

7 January 2021

10.1016/S0140-6736(00)02643-X

Identifiers

DOI

1 reference

27 November 2017

1 reference